tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Mesoblast’s U.S. Origin Designation Shields Products from Tariffs
PremiumCompany AnnouncementsMesoblast’s U.S. Origin Designation Shields Products from Tariffs
1M ago
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
1M ago
Buy Rating for Mesoblast Driven by Strong Ryoncil Launch and Strategic Financial Moves
Premium
Ratings
Buy Rating for Mesoblast Driven by Strong Ryoncil Launch and Strategic Financial Moves
2M ago
Mesoblast Limited Reports 2025 Earnings and Strategic Outlook
PremiumCompany AnnouncementsMesoblast Limited Reports 2025 Earnings and Strategic Outlook
2M ago
Mesoblast reports FY25 net loss ($102.1M) vs. ($88.0M) last year
Premium
The Fly
Mesoblast reports FY25 net loss ($102.1M) vs. ($88.0M) last year
2M ago
Mesoblast options imply 11.6% move in share price post-earnings
Premium
The Fly
Mesoblast options imply 11.6% move in share price post-earnings
2M ago
Mesoblast gives update on Revascor accelerated approval, Ryoncil label extension
PremiumThe FlyMesoblast gives update on Revascor accelerated approval, Ryoncil label extension
5M ago
MESO Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
MESO Earnings Report this Week: Is It a Buy, Ahead of Earnings?
5M ago
Mesoblast gets years of orphan-drug exclusive approval from FDA for Ryoncil
Premium
The Fly
Mesoblast gets years of orphan-drug exclusive approval from FDA for Ryoncil
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100